InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Kazam Joshua A, Director. Officer active across 4 companies, notably TS Innovation Acquisitions Corp.. In total, 9 disclosures have been published. Total volume traded: €333k. The latest transaction was disclosed on 15 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
044,178 shares0
Common Stock
SEC:0001214659-22-008170:0·
0412,618 shares0
Common Stock
SEC:0001214659-22-003836:0·
0211,000 shares0
Common Stock
SEC:0001209191-22-017600:0·
€166,27815,000 shares@ €11.08520.054% mcap100.0% of flow
Common Stock
SEC:0001214659-22-000706·
Ideal exit: 9 Oct 2022 (T+270)
€166,27815,000 shares@ €11.08520.024% mcap100.0% of flow
Common Stock
SEC:0001214659-22-000706:0·
Ideal exit: 9 Oct 2022 (T+270)
016,498 shares0
Common Stock
SEC:0001214659-21-006497·
016,498 shares0
Common Stock
SEC:0001214659-21-006497:0·
30,000 shares
Class A Common Stock
SEC:0000899243-21-022358·
30,000 shares
Class A Common Stock
SEC:0000899243-21-022358:0·
9 of 9 declarations
About Kazam Joshua A
Joshua A. Kazam serves as a board member at TS Innovation Acquisitions Corp. and Allogene Therapeutics, Inc. He plays a key role in overseeing operations and making strategic decisions for these companies. His experience in biotechnology is essential for ensuring the growth and sustainability of these companies.
